PATENT CLAIM ANALYSIS

Application Number: 16271552
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 8):
The method of  claim 1 , wherein the at least one strain of  Roseomonas mucosa  is topically administered to the subject daily over a week.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16271577', '16042939', '16014971', '15939066', '16249721']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7574097232546292
- 35 USC 102 Novelty (BERT): 0.6125025224450248
- Combined Prediction Score: 0.7429190031736688
- Mean Citation Score: 439.296882
- Max Citation Score: 536.4582
- Similarity Product: 514.8867954728721

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test